Targeted Excision of VCP R155H Mutation by Cre- LoxP Technology as a Promising Therapeutic Strategy for Valosin-Containing Protein Disease
Human Gene Therapy Methods · 2015-02 · 26 (1) · 13-24
DOI: 10.1089/hgtb.2014.096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Methods, 2015-02. Verfasst von Angèle Nalbandian und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1 Division of Genetics and Genomics Medicine, Department of Pediatrics, University of California-Irvine , Irvine, CA 92697. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1 Division of Genetics and Genomics Medicine, Department of Pediatrics, University of California-Irvine , Irvine, CA 92697.
Förderung
- NIAMS NIH HHS
Zitieren
APA
Nalbandian, A., Llewellyn, K. J., Nguyen, C., Monuki, E. S., & Kimonis, V. E. (2015). Targeted Excision of VCP R155H Mutation by Cre- LoxP Technology as a Promising Therapeutic Strategy for Valosin-Containing Protein Disease. Human Gene Therapy Methods, 26(1), 13-24. https://doi.org/10.1089/hgtb.2014.096
Vancouver
Nalbandian A, Llewellyn KJ, Nguyen C, Monuki ES, Kimonis VE. Targeted Excision of VCP R155H Mutation by Cre- LoxP Technology as a Promising Therapeutic Strategy for Valosin-Containing Protein Disease. Human Gene Therapy Methods. 2015;26(1):13-24. doi:10.1089/hgtb.2014.096
BibTeX
@article{Nalbandian2015,
author = {Nalbandian, Angèle and Llewellyn, Katrina J and Nguyen, Christopher and Monuki, Edward S and Kimonis, Virginia E},
title = {Targeted Excision of VCP R155H Mutation by Cre- LoxP Technology as a Promising Therapeutic Strategy for Valosin-Containing Protein Disease},
journal = {Human Gene Therapy Methods},
year = {2015},
volume = {26},
number = {1},
pages = {13--24},
doi = {10.1089/hgtb.2014.096}
}
EUVIMED